02-Mar-2026
Download PDF
Nectar Lifescience
We would like to inform you that the Board of the Company at its meeting held on 02.03.2026 has considered and approved the acquisition of 100% paid-up equity share capital of Avensis Exports Private Limited.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
